Loading publications…
The last 5 uploaded publications
Novel microenvironment-based classification of intrahepatic cholangiocarcinoma with therapeutic implications
Miguel A. Martín-Serrano, Benjamin Kepecs, Miguel Torres‐Martín, Emily R. Bramel, Philipp K. Haber, Elliot Merritt, Alexander Rialdi, Nesteene J. Param, Miho Maeda, Katherine E. Lindblad, James K. Carter, Marina Bárcena‐Varela, Vincenzo Mazzaferro, Myron Schwartz, Silvia Affò, Robert F. Schwabe, Augusto Villanueva, Ernesto Guccione, Scott L. Friedman, Amaia Lujambio, Anna S. Tocheva, Josep M. Llovet, Swan N. Thung, Alexander M. Tsankov, Daniela Sia (2022). Novel microenvironment-based classification of intrahepatic cholangiocarcinoma with therapeutic implications. Gut, 72(4), pp. 736-748, DOI: 10.1136/gutjnl-2021-326514.
Article145 days agoWNTinib is a multi-kinase inhibitor with specificity against β-catenin mutant hepatocellular carcinoma
Alexander Rialdi, Mary E. Duffy, Alex P. Scopton, Frank Fonseca, Julia N. Zhao, Megan Schwarz, Pedro Molina-Sánchez, Slim Mzoughi, Elisa Arceci, Jordi Abril‐Fornaguera, Austin Meadows, Marina Ruiz de Galarreta, Denis Torre, Kyna Reyes, Yan Ting Lim, Felix Rosemann, Z.M. Khan, Kevin Mohammed, Xuedi Wang, Xufen Yu, Manikandan Lakshmanan, Ravisankar Rajarethinam, Soo Yong Tan, Jian Jin, Augusto Villanueva, Eleftherios Michailidis, Ype P. de Jong, Charles M. Rice, Ivan Marazzi, Dan Hasson, Josep M. Llovet, Radoslaw M. Sobota, Amaia Lujambio, Ernesto Guccione, Arvin C. Dar (2023). WNTinib is a multi-kinase inhibitor with specificity against β-catenin mutant hepatocellular carcinoma. Nature Cancer, 4(8), pp. 1157-1175, DOI: 10.1038/s43018-023-00609-9.
Article145 days agoIdentification of<i>IGF2</i>as Genomic Driver and Actionable Therapeutic Target in Hepatoblastoma
Jordi Abril‐Fornaguera, Laura Torrens, Carmen Andreu-Oller, Juan Carrillo-Reixach, Alexander Rialdi, Ugne Balaseviciute, Roser Pinyol, Carla Montironi, Philipp K. Haber, Álvaro Del Río-Álvarez, Montserrat Domingo-Sàbat, Laura Royo, Nicholas K. Akers, Catherine E. Willoughby, Judit Peix, Miguel Torres‐Martín, Marc Puigvehí, Stefano Cairo, Margaret Childs, Rudolf Maibach, Rita Alaggio, Piotr Czauderna, Bruce Morland, Bojan Losic, Vincenzo Mazzaferro, Ernesto Guccione, Daniela Sia, Carolina Armengol, Josep M. Llovet (2023). Identification of<i>IGF2</i>as Genomic Driver and Actionable Therapeutic Target in Hepatoblastoma. Molecular Cancer Therapeutics, 22(4), pp. 485-498, DOI: 10.1158/1535-7163.mct-22-0335.
Article145 days ago110 (PB098): Efficacy of WNTinib, a novel selective therapeutic for CTNNB1-mutant tumors, in preclinical models of hepatoblastoma
Ugne Balaseviciute, Jordi Abril‐Fornaguera, Júlia Huguet‐Pradell, Eduardo Fernández‐Martínez, Albert Gris‐Oliver, Alexander Rialdi, Agavni Mesropian, Gulay Ulukaya, Danielle M. Hasson, Ieva Keraite, Roser Pinyol, S N Thung, Ernesto Guccione, Josep M. Llovet (2024). 110 (PB098): Efficacy of WNTinib, a novel selective therapeutic for CTNNB1-mutant tumors, in preclinical models of hepatoblastoma. European Journal of Cancer, 211, pp. 114633-114633, DOI: 10.1016/j.ejca.2024.114633.
Article145 days agoSupplementary Data from Identification of <i>IGF2</i> as Genomic Driver and Actionable Therapeutic Target in Hepatoblastoma
Jordi Abril‐Fornaguera, Laura Torrens, Carmen Andreu-Oller, Juan Carrillo-Reixach, Alexander Rialdi, Ugne Balaseviciute, Roser Pinyol, Carla Montironi, Philipp K. Haber, Álvaro Del Río-Álvarez, Montserrat Domingo-Sàbat, Laura Royo, Nicholas K. Akers, Catherine E. Willoughby, Judit Peix, Miguel Torres‐Martín, Marc Puigvehí, Stefano Cairo, Margaret Childs, Rudolf Maibach, Rita Alaggio, Piotr Czauderna, Bruce Morland, Bojan Losic, Vincenzo Mazzaferro, Ernesto Guccione, Daniela Sia, Carolina Armengol, Josep M. Llovet (2023). Supplementary Data from Identification of <i>IGF2</i> as Genomic Driver and Actionable Therapeutic Target in Hepatoblastoma. , DOI: 10.1158/1535-7163.22495291.
Preprint145 days ago